Multimorbidity and widespread use of clinical guidelines are the main causes for highly
prevalent polypharmacy in older people [1, 2]. Polypharmacy has been identified as a major …

Multimorbidity and polypharmacy represent a major problem for older people. Patients aged
65 years and older may take five or more drugs in 44%(male) and 57%(female) of cases and …

Multimorbidity and, consequently, polypharmacy are highly prevalent in older adults [1, 2].
As the number of older people is continually growing [2, 3], both the concurrent use of …

Background The aging of our societies leads to a higher prevalence of multimorbidity and
therefore polypharmacy, which often results in inappropriate drug treatment. To address this …

Background Drug treatment of older people is still potentially inappropriate in many cases as
multimorbidity and related polypharmacy are highly prevalent. To increase the quality of …

Abstract Background/Objectives Polypharmacy and multimorbidity is a threat to older
people; hence, listing approaches should support physicians to optimize medication. The …

Background: Multimorbidity and polypharmacy are threats to elderly patients; improvement
of medication is important and a novel listing approach (the FORTA list) should support this …

Background Multimorbidity and polypharmacy represent a major problem for elderly
patients; improvement of medication schemes is important and listing approaches (eg Beers …

Purpose Suboptimal drugs therapy is a threat to older people, and listing tools providing
guidance are developed to address this problem. Methods A systematic review was …

Purpose Physicians often face difficulties in choosing appropriate medications for
multimorbid older people. The FORTA (Fit for the Aged) classification (A: absolutely, B …